To the Editor,

 {#ppul24989-sec-0010}

SARS‐CoV‐2 infection has caused a pandemic, which has resulted in more severe disease in adults than children. We report to our knowledge, one of the first reports of COVID‐19 infection in an infant with bronchopulmonary dysplasia (BPD) who developed severe acute respiratory distress syndrome (ARDS), causing bradycardic cardiac arrest and seizures.

A 4‐month‐old male infant was born prematurely at 28 weeks gestation (corrected age is 1 month) with a very low birth weight of 1.315 kg, and was on nasal continuous positive airway pressure/high‐flow nasal cannula (CPAP/HFNC) for 90 days for respiratory distress syndrome at birth. His neonatal intensive care unit (NICU) admission was complicated by human metapneumovirus pneumonia and apnea at 63 days of life. He was weaned off oxygen and discharged home from the NICU 101 days after birth on multivitamins, chlorothiazide, spironolactone, albuterol, and budesonide. He had been home for 2 weeks when he developed cough, nasal congestion, and increased work of breathing 5 days before admission. He was cared for by his parents who were sick with COVID‐19 symptoms. The patient presented to the emergency department with tachypnea, retractions, and hypoxemia with saturation by pulse oximetry of 77%. He developed generalized tonic‐clonic seizures and had a bradycardic cardiac arrest and was resuscitated. There was no history of fever, vomiting, diarrhea, rash, or decrease in oral intake. Initial arterial blood gas analysis was pH 7.20/pCO~2~ 81 mm Hg/pO~2~ 39 mm Hg/bicarbonate 25 mEq/L/base excess −6 on 1.0 fraction of inspired oxygen (FiO~2~) with PaO~2~/FiO~2~ ratio of 39 and oxygenation index of 41. Blood and urine cultures were obtained, broad‐spectrum antibiotics and levetiracetam were started, fluid boluses were given, and chest radiograph (CXR) revealed bilateral opacities with central predominance. He was placed on the ventilator using synchronized intermittent mandatory ventilation/pressure regulated volume control mode (SIMV/PRVC) with FiO~2~ 1.0, positive end‐expiratory pressure (PEEP) 10 cm water, tidal volume 10 cc/kg, rate 40/minute, inspiratory time 0.7 seconds to maintain saturations greater than 90%. The patient was sedated and placed on neuromuscular blockade. Repeat CXR showed significant worsening of bilateral infiltrates (Figure [1](#ppul24989-fig-0001){ref-type="fig"}). Rapid real‐time reverse transcription polymerase chain reaction test was positive for COVID‐19 on nasopharyngeal swab specimen and respiratory viral pathogen panel did not reveal any other viral co‐infections. Initial white cell count was 19.6 × 10^3^/μL with 44% segmented neutrophils, 1% bands, 48% lymphocytes, and 6% monocytes. Hemoglobin was 10.5 g/dL and platelet count was 401 × 10^3^/μL, which decreased in a few hours to 115 × 10^3^/μL. Prothrombin time (PT), partial thromboplastin time (PTT), and international normalized ratio (INR) were slightly increased at 13.9, 1.41, and 26.8 seconds, respectively. The patient received packed red blood cell transfusion, fresh frozen plasma, and vitamin K. C‐reactive protein (CRP) was elevated at 3.68 mg/dL and procalcitonin was high at 0.88 ng/mL. Blood urea nitrogen was 25 mg/dL, serum creatinine was 0.35 mg/dL, and serum sodium was 126 mmol/L and they improved with volume resuscitation. Within 24 hours of hospitalization, patient became hypoxemic with saturation by pulse oximetry of 80% while on SIMV/PRVC with FiO~2~ 1.0 and PEEP of 10 cm water. Inhaled nitric oxide was started at 20 parts per million and within 36 hours patient\'s oxygen saturation decreased to the 70 % and patient was proned. Saturations improved and FiO~2~ was weaned to 0.40 within 8 hours of proning. He was proned for 12 to 14 hours each day for 4 days.
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Video electroencephalogram did not show seizures, head ultrasound revealed a normal study. Echocardiogram showed normal biventricular systolic function with no evidence of pulmonary hypertension. The patient received methylprednisolone 1 mg/kg/dose every 12 hours for 5 days and hydroxychloroquine---6.5 mg/kg/dose every 12 hours on day 1 followed by 6.5 mg/kg/dose once a day for 4 days. Remdesivir was not approved by the manufacturer secondary to severe transaminitis with peak alanine transaminase (ALT) and aspartate transaminase (AST) levels of 1505 and 2297 U/L, respectively, noted within 12 hours of hospitalization. The patient was extubated on hospital day (HD) 8. The patient remained on non‐invasive positive pressure ventilation until HD 22. He was on supplemental oxygen via nasal cannula for another 5 days, which was weaned off and discharged home.

After the first detection of novel coronavirus 2019 (SARS‐CoV‐2) in China in early December 2019 initial studies showed most children were asymptomatic or had mild and moderate symptoms.[^1^](#ppul24989-bib-0001){ref-type="ref"} The percentage of severe and critical cases in pediatric patients with COVID‐19 was 5.9% compared to 18.5% in adult patients. Admission rates to pediatric intensive care units (PICU) range from 9.7% among infected children to 20% of the hospitalized patients.[^2^](#ppul24989-bib-0002){ref-type="ref"}, [^3^](#ppul24989-bib-0003){ref-type="ref"} ARDS has been reported in 3% to 17% of all COVID‐19 patients and in about 60% of children requiring intensive care.[^4^](#ppul24989-bib-0004){ref-type="ref"} Our patient met the Berlin criteria for severe ARDS with PaO~2~/FiO~2~ ratio less than 100. Our patient had worsening hypoxemia and increased inflammatory markers of CRP and procalcitonin, low platelets, and initial acute kidney injury similar to that seen by Chao et al.[^4^](#ppul24989-bib-0004){ref-type="ref"} The severe transaminitis noted in our patient has not been reported in the pediatric studies published thus far.

The underlying risk factors, presentations, management, and outcomes of COVID‐19 in children are still in the process of being understood. Our patient had several risk factors for impaired alveolarization and normal lung growth after birth secondary to the prolonged need for oxygen, respiratory support with CPAP/HFNC, and post‐natal infection with human metapneumovirus. These put him at high risk for ARDS from COVID‐19 that led to hypoxemic acute respiratory failure, bradycardic cardiac arrest, and seizures. Management of COVID‐19 ARDS is complicated by precautions needed during suctioning of small endotracheal tubes in children and the inability to use high‐frequency oscillatory and percussive ventilation strategies secondary to their increased risk of aerosolization. Inhaled nitric oxide was used in our patient even though he did not have pulmonary hypertension to improve refractory hypoxemia as reported in some patients with COVID‐19, but the improvement in oxygenation was only transient in our patient. Proning has been shown to improve oxygenation and compliance in intubated adult COVID‐19 patients.[^5^](#ppul24989-bib-0005){ref-type="ref"} Proning decreases the effects of high PEEP and tidal hyperinflation resulting in decreased ventilator‐associated lung injury and improves lung recruitment.[^6^](#ppul24989-bib-0006){ref-type="ref"} Early proning with meticulous attention to detail can result in favorable outcomes in children with COVID‐19 who have a high risk for ARDS as seen in our patient.
